Kentaro Kai
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Kentaro Kai has a total of 169 co-authors. Here are the top co-authors by number of shared publications:
Hisashi Narahara
Department of Obstetrics and Gynecology, Faculty of Medicine, Oita University, Oita, Japan
15 shared publications- Kaei Nasu
Department of Obstetrics and Gynecology, Faculty of Medicine Oita University Oita Japan
10 shared publications Kaei Nasu
Oita Univ, Div Obstet & Gynecol, Fac Med, Support Syst Community Med, Oita 8790855, Japan
9 shared publicationsYoko Aoyagi
Department of Obstetrics and Gynecology, Oita University Faculty of Medicine, Yufu, JPN
7 shared publicationsMamiko Okamoto
Department of Obstetrics and Gynecology, Oita University Faculty of Medicine, Oita, Japan
6 shared publicationsWakana Abe
Department of Obstetrics and Gynecology, Faculty of Medicine, Oita University, Oita, Japan
6 shared publications
Latest Publications
- Open Access
- 1 January 2027
- Published by XMLink in Journal of Gynecologic Oncology
- Vol. 38
Clinicopathologic features and outcomes of patients with microsatellite instability-high endometrial cancer treated with pembrolizumab in Japan: the KCOG-G1902S/1903S study
Kashima Y, et al. J Gynecol Oncol. 2027 ;38:e19. https://doi.org/10.3802/jgo.2027.38.e19
- 1 January 2027
- Published by XMLink in Journal of Gynecologic Oncology
- Vol. 38
Open AccessClinicopathologic features and outcomes of patients with microsatellite instability-high endometrial cancer treated with pembrolizumab in Japan: the KCOG-G1902S/1903S study
Kashima Y, et al. J Gynecol Oncol. 2027 ;38:e19. https://doi.org/10.3802/jgo.2027.38.e19
- Open Access
- 24 February 2026
- Published by Springer Nature in Cureus
- Vol. 18 (2)
Medical Versus Surgical/Endoscopic Management of Malignant Bowel Obstruction in Patients With End-Stage Gynecologic Cancer: A 12-Year Single-Center Experience
Introduction: Malignant bowel obstruction (MBO) is among the most challenging aspects of late-stage gynecologic cancer care. Surgical/endoscopic interventions carry high complication risks in patients with carcinomatous peritonitis and cachexia. This study examines the impact of surgical/endoscopic interventions on survival time in patients with gynecologic cancer. Methods: We conducted a 12-year retrospective chart review (2013-2024) of all patients with MBO associated with cervical, endometrial, or ovarian cancer who received their initial treatment at our institutions. This MBO cohort was divided into two treatment groups: (i) medical management alone (nasogastric tube, long intestinal tube, octreotide) and (ii) surgical/endoscopic management (percutaneous endoscopic gastrostomy, metallic stent, bypass surgery, stoma formation). The primary outcome measure was 90-day survival from MBO onset; secondary outcome measures included the proportion of patients who, after MBO treatment, recovered oral intake and were discharged home. We compared survival times using Kaplan-Meier analyses and log-rank tests, and analyzed categorical data using the chi-square and Fisher's exact tests. Variables affecting survival time were assessed using the Cox proportional hazards model. Results: A total of 45 cases of MBO were identified among 1,085 gynecologic cancer patients (4.1%). Of these, 95.5% (43/45) underwent some form of medical management. Of these 43 patients, 16 underwent surgical/endoscopic management. The proportion of patients who regained oral intake and were discharged home after MBO treatment was significantly higher in the surgical/endoscopic group (p < 0.001 for both outcomes). In multivariate analysis, surgical/endoscopic treatment was associated with more prolonged survival (hazard ratio (HR) 0.280; 95%CI 0.104-0.754, p = 0.012), whereas ascites severity was associated with shorter survival (HR 2.252; 95%CI 1.015-4.998, p = 0.046). Conclusion: At the end-of-life care for patients with late-stage gynecologic cancer and MBO, we found that surgical/endoscopic intervention better enabled resumption of oral intake and discharge to home without affecting survival time.
- 24 February 2026
- Published by Springer Nature in Cureus
- Vol. 18 (2)
Open AccessMedical Versus Surgical/Endoscopic Management of Malignant Bowel Obstruction in Patients With End-Stage Gynecologic Cancer: A 12-Year Single-Center Experience
Introduction: Malignant bowel obstruction (MBO) is among the most challenging aspects of late-stage gynecologic cancer care. Surgical/endoscopic interventions carry high complication risks in patients with carcinomatous peritonitis and cachexia. This study examines the impact of surgical/endoscopic interventions on survival time in patients with gynecologic cancer. Methods: We conducted a 12-year retrospective chart review (2013-2024) of all patients with MBO associated with cervical, endometrial, or ovarian cancer who received their initial treatment at our institutions. This MBO cohort was divided into two treatment groups: (i) medical management alone (nasogastric tube, long intestinal tube, octreotide) and (ii) surgical/endoscopic management (percutaneous endoscopic gastrostomy, metallic stent, bypass surgery, stoma formation). The primary outcome measure was 90-day survival from MBO onset; secondary outcome measures included the proportion of patients who, after MBO treatment, recovered oral intake and were discharged home. We compared survival times using Kaplan-Meier analyses and log-rank tests, and analyzed categorical data using the chi-square and Fisher's exact tests. Variables affecting survival time were assessed using the Cox proportional hazards model. Results: A total of 45 cases of MBO were identified among 1,085 gynecologic cancer patients (4.1%). Of these, 95.5% (43/45) underwent some form of medical management. Of these 43 patients, 16 underwent surgical/endoscopic management. The proportion of patients who regained oral intake and were discharged home after MBO treatment was significantly higher in the surgical/endoscopic group (p < 0.001 for both outcomes). In multivariate analysis, surgical/endoscopic treatment was associated with more prolonged survival (hazard ratio (HR) 0.280; 95%CI 0.104-0.754, p = 0.012), whereas ascites severity was associated with shorter survival (HR 2.252; 95%CI 1.015-4.998, p = 0.046). Conclusion: At the end-of-life care for patients with late-stage gynecologic cancer and MBO, we found that surgical/endoscopic intervention better enabled resumption of oral intake and discharge to home without affecting survival time.
- Open Access
- 29 March 2025
- Published by Oxford University Press (OUP) in Journal of Surgical Case Reports
- Vol. 2025 (4) , rjaf196
Successful thrombectomy for inferior vena cava thrombosis associated with an ovarian tumor: a case report
A 51-year-old female patient presented with abdominal distension. Computed tomography revealed a right ovarian tumor suspicious for clinical stage IC ovarian cancer, along with a considerable inferior vena cava (IVC) thrombus extending to the Th2 level, accompanied by a deep vein thrombus and a peripheral left pulmonary embolism (PE). Preoperative IVC filter placement was deemed unfavorable due to the short distance between the renal vein and the thrombus. On the second day of hospitalization, ovarian tumor extraction, thrombectomy, and IVC filter placement were performed. Pathology of the excised tumor revealed endometrioid carcinoma. Postoperatively, anticoagulation therapy with edoxaban 30 mg/day resulted in improvement of the deep vein thrombus and PE. The concomitant adnexal resection and thrombectomy rendered the safe placement of an IVC filter feasible despite the preoperative placement being unfeasible. Open thrombectomy remains a valid treatment strategy despite advances in endovascular therapy.
- 29 March 2025
- Published by Oxford University Press (OUP) in Journal of Surgical Case Reports
- Vol. 2025 (4) , rjaf196
Open AccessSuccessful thrombectomy for inferior vena cava thrombosis associated with an ovarian tumor: a case report
A 51-year-old female patient presented with abdominal distension. Computed tomography revealed a right ovarian tumor suspicious for clinical stage IC ovarian cancer, along with a considerable inferior vena cava (IVC) thrombus extending to the Th2 level, accompanied by a deep vein thrombus and a peripheral left pulmonary embolism (PE). Preoperative IVC filter placement was deemed unfavorable due to the short distance between the renal vein and the thrombus. On the second day of hospitalization, ovarian tumor extraction, thrombectomy, and IVC filter placement were performed. Pathology of the excised tumor revealed endometrioid carcinoma. Postoperatively, anticoagulation therapy with edoxaban 30 mg/day resulted in improvement of the deep vein thrombus and PE. The concomitant adnexal resection and thrombectomy rendered the safe placement of an IVC filter feasible despite the preoperative placement being unfeasible. Open thrombectomy remains a valid treatment strategy despite advances in endovascular therapy.
- Open Access
- 19 September 2024
- Published by Elsevier in Radiology Case Reports
- Vol. 19 (12) , 6008-6015
Large cervical endometrioid adenocarcinoma mimicking endometrial endometrioid adenocarcinoma: A case report
- 19 September 2024
- Published by Elsevier in Radiology Case Reports
- Vol. 19 (12) , 6008-6015
Open AccessLarge cervical endometrioid adenocarcinoma mimicking endometrial endometrioid adenocarcinoma: A case report
- Open Access
- 24 January 2024
- Published by Springer Nature in Reproductive Sciences
- Vol. 31 (3) , 857
Correction: MicroRNA-210-3p Regulates Endometriotic Lesion Development by Targeting IGFBP3 in Baboons and Women with Endometriosis
- 24 January 2024
- Published by Springer Nature in Reproductive Sciences
- Vol. 31 (3) , 857
Open AccessCorrection: MicroRNA-210-3p Regulates Endometriotic Lesion Development by Targeting IGFBP3 in Baboons and Women with Endometriosis
- Open Access
- 15 May 2023
- Published by Springer Nature in Reproductive Sciences
- Vol. 30 (10) , 2932-2944
MicroRNA-210-3p Regulates Endometriotic Lesion Development by Targeting IGFBP3 in Baboons and Women with Endometriosis
MicroRNAs (miRs) play an important role in the pathophysiology of endometriosis; however, the role of miR-210 in endometriosis remains unclear. This study explores the role of miR-210 and its targets, IGFBP3 and COL8A1, in ectopic lesion growth and development. Matched eutopic (EuE) and ectopic (EcE) endometrial samples were obtained for analysis from baboons and women with endometriosis. Immortalized human ectopic endometriotic epithelial cells (12Z cells) were utilized for functional assays. Endometriosis was experimentally induced in female baboons (n = 5). Human matched endometrial and endometriotic tissues were obtained from women (n = 9, 18–45 years old) with regular menstrual cycles. Quantitative reverse transcript polymerase chain reaction (RT-qPCR) analysis was performed for in vivo characterization of miR-210, IGFBP3, and COL8A1. In situ hybridization and immunohistochemical analysis were performed for cell-specific localization. Immortalized endometriotic epithelial cell lines (12Z) were utilized for in vitro functional assays. MiR-210 expression was decreased in EcE, while IGFBP3 and COL8A1 expression was increased in EcE. MiR-210 was expressed in the glandular epithelium of EuE but attenuated in those of EcE. IGFBP3 and COL8A1 were expressed in the glandular epithelium of EuE and were increased compared to EcE. MiR-210 overexpression in 12Z cells suppressed IGFBP3 expression and attenuated cell proliferation and migration. MiR-210 repression and subsequent unopposed IGFBP3 expression may contribute to endometriotic lesion development by increasing cell proliferation and migration.
- 15 May 2023
- Published by Springer Nature in Reproductive Sciences
- Vol. 30 (10) , 2932-2944
Open AccessMicroRNA-210-3p Regulates Endometriotic Lesion Development by Targeting IGFBP3 in Baboons and Women with Endometriosis
MicroRNAs (miRs) play an important role in the pathophysiology of endometriosis; however, the role of miR-210 in endometriosis remains unclear. This study explores the role of miR-210 and its targets, IGFBP3 and COL8A1, in ectopic lesion growth and development. Matched eutopic (EuE) and ectopic (EcE) endometrial samples were obtained for analysis from baboons and women with endometriosis. Immortalized human ectopic endometriotic epithelial cells (12Z cells) were utilized for functional assays. Endometriosis was experimentally induced in female baboons (n = 5). Human matched endometrial and endometriotic tissues were obtained from women (n = 9, 18–45 years old) with regular menstrual cycles. Quantitative reverse transcript polymerase chain reaction (RT-qPCR) analysis was performed for in vivo characterization of miR-210, IGFBP3, and COL8A1. In situ hybridization and immunohistochemical analysis were performed for cell-specific localization. Immortalized endometriotic epithelial cell lines (12Z) were utilized for in vitro functional assays. MiR-210 expression was decreased in EcE, while IGFBP3 and COL8A1 expression was increased in EcE. MiR-210 was expressed in the glandular epithelium of EuE but attenuated in those of EcE. IGFBP3 and COL8A1 were expressed in the glandular epithelium of EuE and were increased compared to EcE. MiR-210 overexpression in 12Z cells suppressed IGFBP3 expression and attenuated cell proliferation and migration. MiR-210 repression and subsequent unopposed IGFBP3 expression may contribute to endometriotic lesion development by increasing cell proliferation and migration.
- Open Access
- 28 February 2023
- Published by Springer Nature in Cureus
- Vol. 15 (2) , e35608
Coexistence of Ovarian Endometrioma and Ovarian Pregnancy: A Case Report
Both ovarian pregnancy and endometrioma can rupture and cause life-threatening hemoperitoneum. However, little is known about their coexistence. We report the case of a 34-year-old Japanese woman with a life-threatening hemoperitoneum in the first trimester coexisting with ovarian endometrioma and ovarian pregnancy. The patient was hospitalized in our department for acute hypogastric pain and massive hemoperitoneum during pregnancy. She had a history of miscarriage at eight weeks of gestation one year prior. Her serum beta-human chorionic gonadotropin (hCG) level was >2,000 mIU/mL. Also, a transvaginal ultrasound showed an empty uterus, an intact right ovary, an inhomogeneous left ovary, and a massive hemoperitoneum. An exploratory laparoscopy revealed a rupture of the left ovarian endometrioma, a left corpus luteal cyst, and intraperitoneal bleeding of approximately 1,200 mL. However, no ectopic lesions were observed. Microscopic examination revealed an endometriotic cyst with decidual changes in the stroma, a corpus luteal cyst, and chorionic villi with hemorrhage. Serum beta-hCG levels became negative on the 27th postoperative day. The postoperative course was uneventful. This case shows that, in addition to the differential diagnosis of ovarian pregnancy from ovarian endometrioma, clinicians should consider the coexistence of both conditions.
- 28 February 2023
- Published by Springer Nature in Cureus
- Vol. 15 (2) , e35608
Open AccessCoexistence of Ovarian Endometrioma and Ovarian Pregnancy: A Case Report
Both ovarian pregnancy and endometrioma can rupture and cause life-threatening hemoperitoneum. However, little is known about their coexistence. We report the case of a 34-year-old Japanese woman with a life-threatening hemoperitoneum in the first trimester coexisting with ovarian endometrioma and ovarian pregnancy. The patient was hospitalized in our department for acute hypogastric pain and massive hemoperitoneum during pregnancy. She had a history of miscarriage at eight weeks of gestation one year prior. Her serum beta-human chorionic gonadotropin (hCG) level was >2,000 mIU/mL. Also, a transvaginal ultrasound showed an empty uterus, an intact right ovary, an inhomogeneous left ovary, and a massive hemoperitoneum. An exploratory laparoscopy revealed a rupture of the left ovarian endometrioma, a left corpus luteal cyst, and intraperitoneal bleeding of approximately 1,200 mL. However, no ectopic lesions were observed. Microscopic examination revealed an endometriotic cyst with decidual changes in the stroma, a corpus luteal cyst, and chorionic villi with hemorrhage. Serum beta-hCG levels became negative on the 27th postoperative day. The postoperative course was uneventful. This case shows that, in addition to the differential diagnosis of ovarian pregnancy from ovarian endometrioma, clinicians should consider the coexistence of both conditions.
- 12 April 2022
- Published by Wiley in Journal of Obstetrics and Gynaecology Research
- Vol. 48 (7) , 1961-1967
Factors affecting the recruitment of new obstetrician‐gynecologists in Japan: A report of the MIRAI Committee of the Japanese Society of Obstetrics and Gynecology
Aim There is a chronic shortage of obstetrician-gynecologists in Japan. To increase the number of obstetrician-gynecologists, it is crucial to increase the number of residents being recruited. The purpose of this study was to identify the factors that led students and interns to specialize in obstetrics and gynecology through a questionnaire survey. Methods We sent a questionnaire to the obstetrics and gynecology departments of all the medical schools in Japan (N = 81) and collected data about the institutional background, including the location, total number of obstetrician-gynecologists employed, and number of newly joined obstetrics-gynecology residents and resigned obstetrician-gynecologists and the educational and recruitment activities for medical students and interns. The net balance (increased or decreased) over the fiscal years 2013-2015 was considered a surrogate marker for the number of newly joined obstetrics-gynecology residents. We used binomial logistic regression analysis to determine the factors related to a positive net balance of obstetrician-gynecologists. Results We obtained responses from 59 (72.8%) medical schools. Medical students who observed deliveries were more likely to become obstetrician-gynecologists than those who did not (95% confidence interval: 1.000-1.045, p = 0.052). Medical school location (rural or urban), providing medical students with preparatory lectures for national board examinations, and providing interns with experience as the first assistant during surgery were not associated with an increase in the number of newly joined obstetrician-gynecologists. Conclusions The experience of observing deliveries may encourage medical students to become obstetrician-gynecologists.
- 12 April 2022
- Published by Wiley in Journal of Obstetrics and Gynaecology Research
- Vol. 48 (7) , 1961-1967
Factors affecting the recruitment of new obstetrician‐gynecologists in Japan: A report of the MIRAI Committee of the Japanese Society of Obstetrics and Gynecology
Aim There is a chronic shortage of obstetrician-gynecologists in Japan. To increase the number of obstetrician-gynecologists, it is crucial to increase the number of residents being recruited. The purpose of this study was to identify the factors that led students and interns to specialize in obstetrics and gynecology through a questionnaire survey. Methods We sent a questionnaire to the obstetrics and gynecology departments of all the medical schools in Japan (N = 81) and collected data about the institutional background, including the location, total number of obstetrician-gynecologists employed, and number of newly joined obstetrics-gynecology residents and resigned obstetrician-gynecologists and the educational and recruitment activities for medical students and interns. The net balance (increased or decreased) over the fiscal years 2013-2015 was considered a surrogate marker for the number of newly joined obstetrics-gynecology residents. We used binomial logistic regression analysis to determine the factors related to a positive net balance of obstetrician-gynecologists. Results We obtained responses from 59 (72.8%) medical schools. Medical students who observed deliveries were more likely to become obstetrician-gynecologists than those who did not (95% confidence interval: 1.000-1.045, p = 0.052). Medical school location (rural or urban), providing medical students with preparatory lectures for national board examinations, and providing interns with experience as the first assistant during surgery were not associated with an increase in the number of newly joined obstetrician-gynecologists. Conclusions The experience of observing deliveries may encourage medical students to become obstetrician-gynecologists.
- 1 January 2021
- Published by MRE Press in European Journal of Gynaecological Oncology
- Vol. 42 (2) , 196-198
Neuroendocrine neoplasms in gynaecological malignancies
- 1 January 2021
- Published by MRE Press in European Journal of Gynaecological Oncology
- Vol. 42 (2) , 196-198
Neuroendocrine neoplasms in gynaecological malignancies
- Open Access
- 1 January 2019
- Published by XMLink in Journal of Gynecologic Oncology
- Vol. 30 (6) , e103
Clinicopathologic features, treatment, prognosis and prognostic factors of neuroendocrine carcinoma of the endometrium: a retrospective analysis of 42 cases from the Kansai Clinical Oncology Group/Intergroup study in Japan
We conducted a retrospective, multi-institutional, collaborative study to accumulate cases of neuroendocrine carcinoma of the endometrium, to clarify its clinicopathologic features, treatment, prognosis and prognostic factors to collate findings to establish future individualized treatment regimens. To our knowledge, this is the largest case study and the first study to statistically analyze the prognosis of this disease. At medical institutions participating in the Kansai Clinical Oncology Group/Intergroup, cases diagnosed at a central pathologic review as neuroendocrine carcinoma of the endometrium between 1995 and 2014 were enrolled. We retrospectively analyzed the clinicopathologic features, treatment, prognosis and prognostic factors of this disease. A total of 65 cases were registered from 18 medical institutions in Japan. Of these, 42 (64.6%) cases were diagnosed as neuroendocrine carcinoma of the endometrium based on the central pathological review and thus included in the study. Advanced International Federation of Gynecology and Obstetrics stages (stage III and IV) and pure type small cell neuroendocrine carcinoma cases had a significantly worse prognosis. Upon multivariate analysis, only histologic subtypes and surgery were significant prognostic factors. Pure type cases had a significantly worse prognosis compared to mixed type cases and complete surgery cases had a significantly better prognosis compared to cases with no or incomplete surgery. Our findings suggest that complete surgery improves the prognosis of neuroendocrine carcinoma of the endometrium. Even among cases with advanced disease stages, if complete surgery is expected to be achieved, clinicians should consider curative surgery to improve the prognosis of neuroendocrine carcinoma of the endometrium.
- 1 January 2019
- Published by XMLink in Journal of Gynecologic Oncology
- Vol. 30 (6) , e103
Open AccessClinicopathologic features, treatment, prognosis and prognostic factors of neuroendocrine carcinoma of the endometrium: a retrospective analysis of 42 cases from the Kansai Clinical Oncology Group/Intergroup study in Japan
We conducted a retrospective, multi-institutional, collaborative study to accumulate cases of neuroendocrine carcinoma of the endometrium, to clarify its clinicopathologic features, treatment, prognosis and prognostic factors to collate findings to establish future individualized treatment regimens. To our knowledge, this is the largest case study and the first study to statistically analyze the prognosis of this disease. At medical institutions participating in the Kansai Clinical Oncology Group/Intergroup, cases diagnosed at a central pathologic review as neuroendocrine carcinoma of the endometrium between 1995 and 2014 were enrolled. We retrospectively analyzed the clinicopathologic features, treatment, prognosis and prognostic factors of this disease. A total of 65 cases were registered from 18 medical institutions in Japan. Of these, 42 (64.6%) cases were diagnosed as neuroendocrine carcinoma of the endometrium based on the central pathological review and thus included in the study. Advanced International Federation of Gynecology and Obstetrics stages (stage III and IV) and pure type small cell neuroendocrine carcinoma cases had a significantly worse prognosis. Upon multivariate analysis, only histologic subtypes and surgery were significant prognostic factors. Pure type cases had a significantly worse prognosis compared to mixed type cases and complete surgery cases had a significantly better prognosis compared to cases with no or incomplete surgery. Our findings suggest that complete surgery improves the prognosis of neuroendocrine carcinoma of the endometrium. Even among cases with advanced disease stages, if complete surgery is expected to be achieved, clinicians should consider curative surgery to improve the prognosis of neuroendocrine carcinoma of the endometrium.